In a mouse breast cancer cell model, overexpression of NDRG2 disrupts TGF-β-mediated gene expression and inhibits conversion from latent TGF-β by reducing of integrin β6 expression, which inhibits tumor cell invasion (Figure 4) [28]. Here, NDRG2 is linked to breast carcinoma.